DexCom Inc (NAS:DXCM)
$ 131.91 2.2 (1.7%) Market Cap: 52.46 Bil Enterprise Value: 51.28 Bil PE Ratio: 85.10 PB Ratio: 23.26 GF Score: 89/100

DexCom Inc at Stephens Investor Conference Transcript

Nov 13, 2019 / 03:45PM GMT
Release Date Price: $50.73 (-1.57%)
Christopher Cook Cooley
Stephens Inc., Research Division - MD

Well, good morning, everyone. We'll keep it moving along here. Again, I'm Chris Cooley, the senior medical device analyst here at Stephens. We're honored to have the management team from DexCom with us here today to continue on our medical device track. Long-time friend, Steve Pacelli, here to my right, Executive Vice President of Strategy and Corporate Development. And we also have Sean Christensen as well, the Senior Investor Relations Manager for DexCom. So gentlemen, welcome. I appreciate you joining us here this morning.

Questions & Answers

Christopher Cook Cooley
Stephens Inc., Research Division - MD

We'll just jump right into the Q&A format. And I guess, for me to start, wow, third quarter, 49% annual growth, highest we've seen since early '16. And you did this despite having a number of headwinds that all of us, at least on the sell side, were modeling when we think about Medicare, international markets and the lost PDM sales.

So I guess, a couple of parts to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot